Steve N. Slilaty
2023
In 2023, Steve N. Slilaty earned a total compensation of $560K as Chief Executive Officer and Director at Sunshine Biopharma, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $182,000 |
|---|---|
| Salary | $378,000 |
| Total | $560,000 |
Slilaty received $378K in salary, accounting for 68% of the total pay in 2023.
Slilaty also received $182K in bonus.
Rankings
In 2023, Steve N. Slilaty's compensation ranked 1,787th out of 2,709 executives tracked by ExecPay. In other words, Slilaty earned more than 34.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,787 out of 2,709 | 34th |
Division Manufacturing | 1,032 out of 1,488 | 31st |
Major group Chemicals And Allied Products | 642 out of 835 | 23rd |
Industry group Drugs | 625 out of 801 | 22nd |
Industry Pharmaceutical Preparations | 442 out of 570 | 23rd |
Source: SEC filing on October 17, 2024.
Slilaty's colleagues
We found two more compensation records of executives who worked with Steve N. Slilaty at Sunshine Biopharma in 2023.